Thunderstorm asthma lacks a universally standardized definition, but it is widely understood as a sudden cluster of asthma attacks or bronchospasm symptoms, including coughing and dyspnea, that follows a thunderstorm and results from the interaction between storm conditions and airborne allergens. The first documented outbreak occurred in Birmingham, United Kingdom, in 1983, affecting 106 individuals. Since then, incidents have been reported across Australia, Europe, the Middle East, and China. The most severe event took place in Melbourne, Australia, on November 21, 2016, when more than 1,000 people flooded into emergency rooms and roughly 500 required hospitalization. Although individual outbreaks are rare and often overlooked, a large-scale event can overwhelm healthcare systems with unpredictable consequences and impose a substantial socioeconomic burden, making thunderstorm asthma a genuine public health threat rather than a meteorological curiosity.

The Shanxi study enrolled all 39 patients who presented on the night of the outbreak, drawing clinical data from electronic medical records and subsequent telephone follow-up, and analyzed the findings with descriptive statistics. The demographic picture was strikingly consistent with international precedents. Men accounted for a slightly higher proportion of cases than women, with 20 male and 19 female patients, a pattern echoed in previous reports, one of which found that males made up as much as 58 percent of cases. The mean age of the cohort was 31.62 plus or minus 12.86 years, a figure that the authors note was remarkably close to the mean age of patients during the 2016 Melbourne event. The researchers suggest that this age concentration may reflect a relatively active immune system in young adults, rendering them more susceptible to the allergic airway inflammation that thunderstorm asthma triggers.

Perhaps the most consequential clinical finding concerned allergy history. A review of the patients’ medical histories revealed that 94.87 percent, or 37 of the 39 individuals, had allergic rhinitis, a figure that closely matches earlier research by Nur-Shirin Harun and colleagues, who found that over 90 percent of thunderstorm asthma patients had the condition. This convergence underscores a central risk factor: people with pollen-sensitized airways, even those who have never experienced a full asthma attack, are the primary targets of these epidemics. Laboratory data, though limited, reinforced the allergic picture. Blood tests were performed on only 8 patients, and 5 of them, or 62.5 percent, showed elevated peripheral blood eosinophil counts above 0.52 times 10 to the ninth per liter, a hallmark of type 2 allergic inflammation. The authors acknowledge that the small number of tested patients represents a gap, and they call for future research to identify specific diagnostic biomarkers that could aid clinicians in diagnosis and prognostic evaluation.

The mechanism behind thunderstorm asthma is a story of atmospheric physics colliding with immunology. During a thunderstorm, strong winds carry allergenic pollen grains into the humid cloud layer, where they absorb moisture and rupture, releasing allergen-carrying particles ranging from 0.03 to 4 micrometers in size. These micro-particles are then driven back to ground level by downdrafts, creating a high concentration of respirable allergens exactly where sensitized people are breathing. Studies have confirmed a significant increase in these fragmented pollen particles after thunderstorms. The high concentration of positive ions in the air during storms may also interact with negatively charged pollen grains, potentially facilitating their rupture and further increasing airborne allergen loads. In northern China, early autumn is the peak season for Artemisia pollen, which interacts with thunderstorm conditions to form the respirable particles that set off the attacks. A separate outbreak reported in Hohhot on September 1, consistent with the timing of the Shanxi event, reinforces the conclusion that these epidemics in northern China cluster in early autumn and center on Artemisia species.

Once the microscopic particles are inhaled, the immune cascade unfolds with textbook precision. Particles smaller than 10 micrometers can reach the bronchi, where dendritic cells act as antigen-presenting cells, phagocytosing the pollen proteins and processing them into fragments recognizable by T cells. These antigens are presented to CD4-positive T cells via MHC Class II molecules, activating them to differentiate into T-helper 2 cells. The activated Th2 cells release cytokines including IL-4, IL-5, and IL-13. IL-4 stimulates goblet cells in the airways to produce excess mucus and promotes B cell differentiation and the production of IgE antibodies, which bind to receptors on mast cells, eosinophils, and airway smooth muscle cells. Upon re-exposure, the allergen cross-links the bound IgE, triggering these cells to release mediators that cause airway smooth muscle contraction and further mucus secretion, culminating in the irritating cough and dyspnea that brought the Shanxi patients to the hospital. The initial exposure to Artemisia pollen particles may sensitize the immune system and form a memory response, so the storm essentially delivers a massive re-exposure dose to a population already primed for reaction.

On the treatment side, the emergency department activated its contingency plan, recalling off-duty first-line medical staff to manage the rapid surge of patients presenting with chest tightness, cough, wheezing, and dyspnea. Life-threatening cases would have required immediate resuscitation, but fortunately none of the 39 patients developed life-threatening conditions. The pharmacological backbone of care consisted of nebulized medications: budesonide inhalation suspension, an inhaled corticosteroid that suppresses the activation of inflammatory cells and the release of allergic mediators, thereby reducing airway hyperresponsiveness; terbutaline sulfate inhalation solution, a short-acting beta-2 adrenergic agonist that selectively stimulates beta-2 adrenoceptors on airway smooth muscle, inducing bronchial relaxation and rapidly relieving acute bronchospasm; and ipratropium bromide inhalation solution, a short-acting muscarinic antagonist that competitively blocks airway muscarinic receptors, attenuating vagally mediated bronchoconstriction and reducing mucus hypersecretion.

The medication distribution revealed the practical logic of the response. The most common regimen, combining budesonide inhalation suspension with terbutaline sulfate inhalation solution, was administered to 23 patients, or 58.97 percent of the cohort, while 10 patients, or 25.64 percent, received budesonide combined with ipratropium bromide. Four patients received budesonide alone and four received formoterol. For more severe cases, methylprednisolone sodium succinate for injection was used in 2 patients. Notably, 32 patients, or 82.05 percent, received oral montelukast sodium therapy, a leukotriene receptor antagonist. The authors point out that pharmacological management of thunderstorm asthma still shows considerable heterogeneity in clinical practice, and that exploration and consensus regarding standardized preventive medication strategies remain inadequate and require further supplementation. Combined application of inhaled medications, they note, may help alleviate acute symptoms and reduce the persistence of acute exacerbations.

One month after the event, telephone follow-up found that the patients reported no recurrence-related discomfort after discharge and had gained an understanding of the disease and its preventive measures. The authors were strongly advising patients to seek immediate medical help if breathing difficulties persisted. Beyond individual care, the study draws a lesson from Australia: after the 2016 Melbourne epidemic, the country established an environmental monitoring system with a multi-level public alert system disseminated via media, allowing sensitized individuals to take preventive measures such as staying indoors and using bronchodilators while alerting healthcare systems to prepare. The Shanxi team recommends that health authorities develop integrated early warning systems combining environmental monitoring and public communication, and suggests that monitoring instruments targeting allergen concentrations could be engineered to forecast ambient allergen loads and generate early alerts, enabling patients to implement appropriate preventive strategies.

The broader message from Taiyuan is that thunderstorm asthma is no longer a phenomenon confined to Melbourne’s grass pollen springs. Northern China’s early autumn Artemisia season, coinciding with late-summer thunderstorms, creates a recurring window of risk that health systems must now anticipate. The authors argue that hospitals must develop specific thunderstorm asthma emergency response plans, with adequate material reserves as the foundation, supported by robust training on standardized management protocols and workflows. They also call for enhanced health education and public science promotion during the early autumn season to prevent future outbreaks. As climate change alters pollen seasons and storm frequency, as Beggs argued in JAMA in 2024, the intersection of violent weather and airborne allergens may become less rare, making the Shanxi episode both a warning and a template for emergency departments across the region.

Subject of Research: Epidemic thunderstorm asthma outbreak linked to Artemisia pollen in Shanxi, China

Article Title: Episode of epidemic thunderstorm asthma in Shanxi China September 2025: epidemiological characteristics, mechanisms, and emergency management strategies

Article References: Shen, T., Guo, G., Li, H., Wang, J., Wang, H., & Mi, J. (2026). Episode of epidemic thunderstorm asthma in Shanxi China September 2025: epidemiological characteristics, mechanisms, and emergency management strategies. Frontiers in Medicine, 13, Article 1953484. https://doi.org/10.3389/fmed.2026.1953484

Image Credits: AI Generated

DOI: 10.3389/fmed.2026.1953484

Keywords: thunderstorm asthma, Artemisia pollen, allergic rhinitis, IgE-mediated inflammation, eosinophils, emergency department, budesonide, terbutaline, ipratropium bromide, montelukast, early warning systems, northern China

The stakes are unusually high in Melbourne. In November 2016, the city experienced the world’s largest epidemic thunderstorm asthma event, a night in which a severe storm shattered grass pollen grains into respirable fragments and sent thousands of asthmatics to emergency departments, overwhelming ambulance services and contributing to multiple deaths. Since 2017, the Victorian government has operated a daily epidemic thunderstorm asthma risk forecasting system during the grass pollen season from October to December. That system combines severe weather forecasts with district-level grass pollen forecasts, and the pollen forecasts depend entirely on a statewide network of manual Hirst-type traps staffed by trained counters. Those human measurements carry a well-recognised uncertainty of roughly plus or minus thirty percent in daily pollen levels, arising from variable sampling efficiency and the inherent fallibility of human identification and counting. Any upgrade to that surveillance backbone must therefore be proven, not assumed.

The trial ran for 92 days, from October 1 to December 31, 2022, spanning the southern hemisphere spring and early summer. Over that period Melbourne recorded 265.3 millimetres of rain across 37 wet days, a maximum temperature of 37 degrees Celsius in late December, and a minimum of 5.2 degrees in late October. Both instruments sat 28.4 metres above ground level on the roof of the Earth Sciences building, roughly two kilometres north of the central business district, a siting that complies with Australian and New Zealand standards for ambient air sampling. The Burkard trap produced data for 88 of the 92 days; the automated instrument ran continuously for the entire trial. Grass and cypress pollen were the focus because together they account for nearly seventy percent of the total pollen load in Melbourne’s springtime air.

The technical comparison followed the analytical framework of a large 2023 European evaluation of nine automated pollen instruments, allowing direct benchmarking against international results. The researchers calculated the coefficient of determination, or R-squared, to measure the strength of the linear relationship between the two systems, the slope of the best-fit line to detect proportional bias, and the mean absolute error to quantify typical disagreement. For total daily pollen, the automated instrument achieved an R-squared of 0.92 with a slope of 1.1, meaning it tracked the manual counts closely while reading slightly high on average. For grass pollen, the single most important taxon for thunderstorm asthma forecasting, the agreement was equally strong: R-squared of 0.92, a slope of 1.1, and a mean absolute error of 11.6 grains per cubic metre. Cypress pollen came in at R-squared of 0.86. Those figures match or exceed the performance reported for the same instrument in Munich, a result the authors attribute partly to the dominance of grass and cypress in Melbourne’s air, both of which the classifier can recognise.

The category analysis is where the results become genuinely striking for public health. Victoria does not report raw grass pollen numbers to the public; instead, daily levels are assigned to three operational thresholds: low, from zero to 19 grains per cubic metre; moderate, from 20 to 49; and high, at 50 or more. These categories feed directly into the thunderstorm asthma risk matrix and public advisories. Across the 88 paired days, the two instruments placed 72 days in the same category. Of the 16 mismatches, 12 fell between the low and moderate boundaries and only four between moderate and high, a pattern consistent with the known tendency of co-located pollen instruments to diverge most at low concentrations. Critically, the automated system detected high-pollen days with a probability of 0.96, achieved a Gerrity skill score of 0.82, and produced no false positives and no false negatives for high-pollen days. That last detail matters enormously: false positives trigger unnecessary alerts, eroding public trust and costing agencies money, while false negatives leave vulnerable people unprotected during genuinely dangerous conditions.

Beyond daily totals, the trial tested whether the automated counter could resolve the sub-daily structure that manual counting simply cannot see. Twelve days spanning the November midpoint of the season were selected for three-hourly analysis, yielding 96 paired observations. Both instruments showed the expected diurnal rhythm, with 65 to 75 percent of each day’s pollen released during daylight hours and concentrations falling overnight. At three-hourly resolution the linear relationship weakened modestly, to R-squared of 0.86 for total pollen and 0.81 for grass, with correspondingly larger mean absolute errors, but the slopes remained close to those of the daily comparison. To validate that this rhythm was real rather than an artefact, the team compared both instruments against the Victorian Grass Pollen Emissions Module, a physics-based dispersion model driven by downscaled meteorological data. Both instruments correlated strongly with the model’s predictions, confirming that the automated system faithfully captured the day-to-night cycle that underpins understanding of how pollen exposure evolves ahead of storm events.

Cypress pollen exposed the limits of importing a classifier trained on European air. The MeteoSwiss 2022 model distinguishes Cupressus from Taxus, two conifer genera whose grains look nearly identical and are usually merged into a single category in aerobiological studies. Because yew trees are uncommon in Melbourne, the researchers reassigned all automated Taxus counts to Cupressus, applying the appropriate scaling factor. Even after this correction, the automated cypress integral came out more than double the manual one, driven largely by discrepancies late in the season. The statistics were also heavily influenced by an extreme event on October 12, when roughly forty percent of the season’s entire cypress load arrived in a single day. Removing that outlier pushed the regression slope from 1.0 to 2.2 while leaving R-squared largely intact. The authors are candid that this signals a need for locally adapted classifier training, though they stress the problem was confined to cypress and did not contaminate the grass or total pollen comparisons.

The study is honest about its constraints. The reference instrument itself is not an absolute ground truth; manual Hirst-type counting carries its own sampling and preparation uncertainties, so the trial measured operational comparability with the existing standard rather than perfect accuracy. The classifier was built for Swiss aerobiology, not Australian, which is precisely why some taxa needed local interpretation. The sub-daily analysis covered a focused subset of days, and the trial did not link pollen measurements directly to health outcomes such as ambulance call-outs or emergency presentations. Generalising to regions where native Myrtaceae pollen dominates, a family the classifier cannot identify at all, will require further evaluation across additional Australian sites and seasons. Notably, the automated instrument still recorded a total pollen integral 25 percent higher than the manual trap despite lacking classifiers for several common local pollen types, suggesting the two systems weight the airborne particle load differently.

What the trial ultimately demonstrates is a turning point for aerobiology. The SwisensPoleno Mars sampled air at 40 litres per minute, four times the flow of the Burkard trap, identified particles between 2 and 300 micrometres using light scattering and holographic imaging at a resolution of 0.595 micrometres per pixel, and streamed results continuously to an offsite server without a single technician touching a slide. For grass pollen, the taxon that decides whether Melbourne’s emergency services brace for a thunderstorm asthma event, the machine matched the human standard almost perfectly and never once confused a dangerous day with a safe one. The researchers conclude that automated counters are ready to supplement or replace manual counting in Victoria’s monitoring network, and that their real added value lies in the high temporal resolution they unlock: the ability to watch pollen concentrations rise hour by hour, exactly the kind of rapid change that precedes the storms that turned a November evening in 2016 into a public health emergency.

Subject of Research: Evaluation of an automated pollen monitor against manual Hirst-type trapping for thunderstorm asthma forecasting in Melbourne, Australia

Article Title: Evaluating automated pollen monitoring for thunderstorm asthma and public health forecasting: a comparative study in Melbourne, Australia

Article References: Lampugnani, E. R., Nattala, U., Csutoros, D., Sniderman, K., Picking, B., Emmerson, K. M., Graf, E., Zeder, Y., Niederberger, E., & Newbigin, E. (2026). Evaluating automated pollen monitoring for thunderstorm asthma and public health forecasting: a comparative study in Melbourne, Australia. Environmental Monitoring and Assessment, 198(11), Article 1187. https://doi.org/10.1007/s10661-026-16017-2

Image Credits: AI Generated

DOI: 10.1007/s10661-026-16017-2

Keywords: pollen monitoring, thunderstorm asthma, automated pollen counter, SwisensPoleno Mars, Hirst trap, grass pollen, cypress pollen, machine learning, digital holography, Melbourne, public health forecasting, aerobiology

The biological case for pediatric vulnerability rests on basic physiology. Children breathe more air per kilogram of body weight than adults, in part because their higher ventilation rates and greater oronasal partitioning toward mouth breathing increase the dose of any airborne pollutant delivered to the lower airways. Their airways are also narrower and still developing, so a given degree of inflammation or mucus production produces proportionally greater obstruction. The review emphasizes that children’s immune responses are immunologically immature and skewed toward the type 2 inflammatory pathways that define allergic asthma, meaning that environmental insults arriving during early life can both provoke acute attacks and shape the trajectory of the disease itself. When these anatomical and immunological factors combine with socioeconomic and structural disparities—substandard housing, proximity to traffic corridors, limited access to care—the burden of climate-amplified exacerbations concentrates among the children least equipped to escape it.

Air pollution remains the most extensively quantified trigger, and the review details the cellular choreography by which it initiates an attack. Particulate matter, ozone, nitrogen dioxide and diesel exhaust particles generate reactive oxygen species in the airway epithelium, damaging the barrier that normally keeps the lung’s immune system calm. Injured epithelial cells release alarmins and inflammatory mediators, and experimental work shows that diesel exhaust particles can upregulate interleukin-17A expression through ROS-dependent NF-κB signaling in airway epithelial cells, feeding neutrophilic and mixed inflammatory responses. Ozone, a powerful oxidant formed photochemically from precursor pollutants, is particularly adept at provoking epithelial injury and airway hyperresponsiveness. Global burden-of-disease analyses cited in the review attribute substantial numbers of new asthma cases and emergency room visits to ambient PM2.5, ozone and nitrogen dioxide, and meta-analyses of outdoor pollution consistently link short-term exposure spikes to exacerbations in both children and adults.

What elevates this familiar story into a climate story is the feedback between warming and pollution chemistry. Ground-level ozone formation accelerates with temperature, so heat waves and ozone episodes increasingly arrive together, compounding respiratory stress. Climate-attribution modeling has begun to disentangle how much of future pollution-related mortality and asthma morbidity will be driven by climate change itself rather than by emissions alone, with projections suggesting that a warming world will partially offset gains from cleaner air in some regions while worsening them in others. The review also highlights wildfire smoke as a rapidly growing climate-linked pollution source: attribution studies indicate that anthropogenic climate change has played a large role in driving smoke concentrations across the western United States, and epidemiological work has directly tied climate-change-induced wildfire smoke to asthma exacerbations in that region. Fine particles in smoke penetrate deep into the lung, and children in smoke-affected communities have shown measurable increases in asthma-related emergency visits during major fire events.

Temperature emerges as a second major axis, operating through mechanisms distinct from pollution. Extreme heat triggers oxidative stress, activates bronchial C-fiber sensory nerves and promotes systemic inflammation; in susceptible patients, simply breathing hot humid air can provoke bronchoconstriction through a cholinergic reflex, a finding demonstrated experimentally in asthmatic subjects. Time-series studies from Atlanta, Maryland, Montreal and elsewhere show that warm-season temperature extremes and heat events are associated with increased asthma-related emergency department visits and hospitalizations in children, and case-crossover analyses in Ontario have extended the pediatric heat signal to extreme heat days more broadly. Cold is not protective: longitudinal data from eighteen Chinese cities identified cold temperatures and sudden temperature drops as novel risk factors for exacerbation, and mouse models show that both high and low temperature extremes aggravate airway inflammation. Gene-expression studies suggest extreme temperatures can even reprogram the airway epithelium in mice and asthma patients, hinting at mechanisms that outlast the weather event itself.

The review’s treatment of relative humidity is among its most technically interesting sections. As the atmosphere warms, tropospheric relative humidity stays near constant globally while relative humidity over land declines, a divergence explained by the fact that land warms faster than the ocean surface that supplies its moisture. For the human airway, both directions matter. At low humidity, inspired air dehydrates the respiratory mucosa, and recent work in Communications Earth & Environment argues that global warming risks dehydrating and inflaming human airways directly, compromising the epithelial defenses that depend on a well-hydrated mucus layer. At high humidity, mucus clearance becomes impaired, and humid-heat combinations captured by indices such as the humidex have been linked to childhood asthma hospitalizations in time-series analyses from Hefei, China. Humidity also modifies pollution toxicity: studies in Romania found that the respiratory effects of ambient air pollution varied with air humidity, meaning that climate-driven shifts in moisture regimes can change the dose-response relationship children experience on any given day.

Beyond the three headline exposures, the review maps a web of indirect climate pathways. Lengthening pollen seasons—documented across North America through attribution analyses linking anthropogenic warming to extended and more intense allergen release—prolong the period during which sensitized children hover near the threshold of an attack. Transitional weather in spring and autumn favors the circulation of respiratory viruses, the single most common precipitant of pediatric exacerbations, and shifting season lengths alter when these viral windows overlap with pollution and pollen peaks. Extreme weather events add acute shocks: thunderstorm asthma outbreaks occur when storm outflows rupture pollen grains into respirable fragments; hurricanes and floods damage housing and mold-infest interiors; and dust storms in arid regions have been tied to asthma hospitalizations and respiratory emergency visits in Chinese cities. Each pathway operates on a different timescale, from minutes during a thunderstorm to decades of shifting seasonal norms, but all converge on the same vulnerable airway.

The authors are candid about the limits of current knowledge. Climate attribution—the quantitative assignment of a fraction of observed health outcomes to human-caused warming—has been achieved for only selected exposures, chiefly heat, wildfire smoke and ozone, while the pediatric-specific contribution of humidity shifts, dust storms and viral seasonality remains poorly quantified. Most epidemiological studies measure single pollutants or single meteorological variables, yet children are exposed to mixtures, and emerging work on joint pollutant-mixture associations suggests interactions that single-exposure models miss. Disentangling the independent effect of climate change from concurrent changes in emissions, land use and healthcare access is methodologically demanding, and the review calls for closing these attribution gaps as a research priority, particularly for the low- and middle-income settings where pediatric asthma prevalence is rising fastest.

The practical response the authors propose is adaptation now, not merely mitigation later. Heat-health and air-quality warning systems can give families and clinicians hours of lead time before dangerous conditions arrive; environmental adaptation measures, from improved housing ventilation and filtration to urban greening that cools heat islands, reduce the dose of triggers children actually receive; and equity-focused targeting directs these interventions to the high-risk populations where environmental injustice has already been shown to worsen asthma outcomes among school-age children. Deep-learning models trained on environmental variables are even being tested to forecast asthma patient volumes, offering health systems a way to anticipate surges. The review’s impact statement distills the argument: climate change amplifies the environmental triggers of pediatric asthma exacerbations, children’s physiology heightens their sensitivity to those triggers, and integrating climate-adaptation strategies into routine asthma care could measurably reduce the burden. In a century defined by warming, the authors suggest, the pediatric asthma action plan may need a new first line: check the forecast.

Subject of Research: Climate change effects on pediatric asthma exacerbations through air pollution, temperature and relative humidity

Article Title: Climate change, environmental exposures, and pediatric asthma exacerbations: air pollution, temperature, and relative humidity

Article References: Tran, X. N., Lee, Y.-L., Chang, L.-T., Chang, T.-Y., Chuang, K.-J., Ho, K.-F., Chung, K. F., Chang, J.-H., & Chuang, H.-C. (2026). Climate change, environmental exposures, and pediatric asthma exacerbations: air pollution, temperature, and relative humidity. Pediatric Research. https://doi.org/10.1038/s41390-026-05418-1

Image Credits: AI Generated

DOI: 10.1038/s41390-026-05418-1

Keywords: pediatric asthma, climate change, air pollution, extreme heat, relative humidity, wildfire smoke, ozone, pollen, thunderstorm asthma, respiratory viruses, environmental justice, asthma exacerbations